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ABSTRACT
High systemic levels of oestrogens are cholestatic and primary biliary cholangitis (PBC)—which is characterized by hepatic
ductular inflammation—is thought to be triggered by exposure to xenobiotics such as those around landfill sites.
Xenoestrogens may be a component of this chemical trigger. We therefore hypothesized that xenoestrogens are present at
higher levels in the proximity of landfill sites. To test this hypothesis, soil samples were collected, extracts prepared and
biological oestrogenic activity examined using cell-based reporter gene assays. Extracts from several sample sites around a
landfill site contained a chemical(s) which activated the human ERa in a dose-dependent manner. Extracts from 3 separate
control sampling sites were absent of any detectable activity. The mouse ERa and 2 variant mouse ERb cDNAs were cloned
and extracts from sample sites around a landfill site also activated these receptors. One variant murine ERb was
constitutively active when expressed in cholangiocytes, was readily inactivated by ICI182780 and activated in a dose-
responsive, ICI182780-inhibitable manner by oestrogen. However, when this receptor was activated by extracts from landfill
site soils, ICI182780 failed to antagonize activation. ERb was readily detectable in murine cholangiocytes and exposing
mice acutely to a pooled ER activating soil extracts also gave rise to a mild cholestatic injury. These data indicate that the
environment around landfill sites may contain higher levels of xenoestrogens; that these chemicals have “super-
activating” characteristics with a variant ERb and therefore these chemicals could be a component of a xenobiotic insult
that triggers PBC.
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A variety of man-made chemicals released into the environ-
ment by anthropogenic activity (eg, pesticides) have been
shown to act as endocrine disruptors and have been proposed
to be responsible for a spectrum of adverse effects in wildlife
and man, from malformations in the male genital tract; de-
creased sperm quality; neuroendocrinological, behavioural and
metabolic effects to cancer (Alonso-Magdalena et al., 2011;
Mattison et al., 2014; Soto and Sonnenschein, 2010). Oestrogens
(estrogens) are a class of steroid hormones initially defined
on the basis of their ability to bind and activate the oestrogen
receptors (ERs) (Bondesson et al., 2015). The main oestrogen in
humans is 17b oestradiol (E2) although other circulating oestro-
gens having biological activity on the human ERs include oes-
trone (E1) and oestriol (E3) (Bondesson et al., 2015).
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Oestrogens are primarily produced in the ovaries or testes
from testosterone and androstenedione (to produce E2 and E1,
respectively) through metabolism by aromatase, and their ma-
jor biological function in women is to regulate the variety of
physiological changes associated with female reproduction
(in sexually mature women) (Bondesson et al., 2015). These
changes most obviously include developmental changes in
reproductive-relevant tissues such as the uterus and breast.
However, oestrogens also regulate metabolic changes associ-
ated with actions on other tissues eg, hepatic synthesis of sex
hormone binding globulin (Hammond, 2011); hepatic meta-
bolic effects (Mauvais-Jarvis et al., 2013). The majority of ef-
fects of oestrogens are widely considered to be mediated
through their interaction with ERs. ERs are members of the
nuclear receptor gene superfamily of Zn finger-containing
transcription factors which—in response to interactions with
specific ligands—modulate the transcription of genes regu-
lated by response element sequences that bind the nuclear re-
ceptor complexes (Bondesson et al., 2015). Thus, the sequence
of the response element is a major determinant in conferring
regulation by a particular ligand via its interacting nuclear
receptor.
Two ER genes are present within the human genome - ERa
(NR3A1) and ERb (NR3A2) and their products are both activated
by E2 (Bondesson et al., 2015). ERa is expressed at high levels in
uterine, ovarian, pituitary gland, vas deferens and adipose tis-
sues (Nuclear Receptor Signaling Atlas www.nursa.org/; last
accessed November 18, 2016) and the primary role of ERa is the
regulation of sexual reproduction, as exemplified in ERa knock
out mice—females are infertile and males have decreased fertil-
ity (Lubahn et al., 1993). ERb expression is highest in the ovary,
lung, epididymis, prostate, colon and specific regions of the
brain (Nuclear Receptor Signalling Atlas www.nursa.org/). ERb
knockout mice develop relatively normally and have normal
fertility (Krege et al., 1998). Additional receptors for oestrogens
have been identified which expand the potential mechanism by
which oestrogens and xenoestrogens may affect cells. These in-
clude other nuclear receptors such as the oestrogen-related re-
ceptors which bind some isoflavones, but not E2 (Suetsugi et al.,
2003) and the constitutive androstane receptor in both mouse
(Kawamoto et al., 2000) and man (Koh et al., 2012). In addition,
the non-genomic effects of oestrogens may be mediated via ERs
(or potentially other oestrogen-binding nuclear receptors) lo-
cated on membranes and acting in a relative rapid (ie, minutes
rather than the hours required for transcriptional changes),
non-canonical manner (Rainville et al., 2015). Oestrogen binding
proteins that are structurally unrelated to nuclear receptors (eg,
GPER1, also known as GPR30), are often membrane associated
and have also been identified to mediate non-genomic rapid ef-
fects of oestrogens (such as kinase activation and changes in in-
tracellular calcium) (Rainville et al., 2015).
Xenoestrogens are exogenous chemicals which mimic the
activity of oestrogens through their interaction with cellular
components that interact with endogenous oestrogens and
through these interactions modulate the normal levels and/or
endocrine activity of oestrogens. Xenoestrogens include chemi-
cals naturally present in our diet eg, isoflavones (Kuiper et al.,
1998) and a variety of synthetic man-made chemicals eg,
bisphenol A (Laws et al., 2000). Thus, a xenoestrogen may be a
chemical that interacts with receptor proteins mediating the bi-
ological effect of oestrogens as hormones. However, other
mechanisms of xenoestrogen action also exist, related to any bi-
ologically relevant alteration in oestrogen bioavailability. Thus,
a chemical that causes alterations in oestrogen synthesis,
sequestration, dynamic activity, metabolism and/or excretion
could be defined as a xenoestrogen.
The liver is considered a hormonal target for oestrogens via
ERa (Ahlbory-Dieker et al., 2009) and plays a major role in deter-
mining the circulating levels of oestrogens via metabolic con-
version of oestrogens to inactive products (Bondesson et al.,
2015; Tsuchiya et al., 2005; Ziegler et al., 2015). Its importance is
exemplified by the feminisation that occurs in men with
chronic liver disease due, in part, to impaired hepatic oestrogen
metabolism and clearance (Burra, 2013). The liver is also a target
organ for the toxic effects of oestrogens—the classic response
being that of a disruption of bile flow and/or alteration in bile
constituents (cholestasis). Cholestasis leads to an accumulation
of bile acids in the liver, which is toxic and results in liver cell
necrosis and apoptosis as well as systemic adverse effects eg,
pruritis (Woolbright and Jaeschke, 2012). In susceptible individ-
uals, the elevations in circulating oestrogens in pregnancy or
through use of contraceptives can be sufficient to lead to he-
patic failure and death in the absence of liver transplantation
(Ozkan et al., 2015). In terms of natural oestrogens and adverse
hepatic effects, Stieger et al. (2000) proposed that oestrogen and/
or its hepatic metabolites inhibit the activity of bile acid and
drug transporters to initiate cholestasis. However, in 2006,
Negishi and co-workers elegantly demonstrated that the ex-
pression of many bile acid and drug transporters are transcrip-
tionally repressed by ERa activation, an effect lost in ERa null
mice (Yamamoto et al., 2006). These latter data therefore suggest
that xenoestrogens having a potential adverse effect in the liver
may be identified by their interaction with the ERa.
Primary Biliary Cholangitis (PBC) is a chronic liver disease
thought to be of an autoimmune aetiology due to the presence
of antibodies to mitochondrial proteins in the majority of PBC
patients (Dyson et al., 2015; Griffiths and Jones, 2014). At present,
treatment options for PBC are limited and there are no proven
strategies to prevent the onset of the disease in individuals
known to be at risk of the disease (including the daughters of
mothers with the disease who have a 35-fold increased risk of
developing the disease). PBC is triggered in genetically predis-
posed individuals through exposure to an unknown chemical(s).
Much of the epidemiology over the last few decades has linked
PBC to chemicals such as the use of hair dyes; to proximity to
toxic landfill sites and to areas of heavy mining (Ala et al., 2006;
Prince et al., 2001; Smyk et al., 2010). Although some chemicals
have been shown to trigger a PBC-like effect in mouse models
(Wakabayashi et al., 2008; Walden et al., 2008), actual chemical(s)
trigger in the environment and causative mechanism(s) for the
disease are unknown.
Previous investigations have suggested that only ERa is ex-
pressed in hepatocytes whereas both ERa and ERb are expressed
in cholangiocytes and markedly upregulated in disease settings.
It has been considered that through actions on both (ERa) and
(ERb) subtypes, oestrogens regulate the expression of growth
factors and cytokines, thereby modulating the proliferative re-
sponse of cholangiocytes to damage (Alvaro et al., 2004, 2006).
Given the widespread concern regarding man-made xenoes-
trogen chemicals and adverse health effects, we hypothesized
that the environment around landfill sites contains a variety of
xenoestrogens and that chronic exposure may give rise to some
of the effects associated with endocrine disruptors, such as cho-
lestasis. To test this hypothesis, soil samples were taken from
around a currently active peri-urban landfill site positioned
upon an area of historic mining (and from 3 separate control
sampling sites), chemicals were extracted into an ethanol sol-
vent and the presence of oestrogenic chemicals tested in
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biological assays (human and mouse ER-luciferase reporter
gene assays).
In this article, we demonstrate that several landfill sample
sites contained oestrogenic chemicals, and in contrast to E2, be-
haved as irreversible agonists of a murine ERb variant in a pan-
creatohepatobiliary cell context. Acute exposure of mice to a
pooled oestrogenic environmental sample also resulted in evi-
dence of cholestasis.
MATERIALS ANDMETHODS
The mouse cholangiocyte cell line 603B was a gift from Dr
Yedidya Saiman, Mount Sinai School of Medicine, New York.
The mouse pancreatic ductal cell line LTPA was originally ob-
tained from the American Type Culture Collection (ATCC, cata-
log CRL-2389, Manassas, Virginia) and is an epithelial cell line
derived from a spontaneous pancreatic adenocarcinoma taken
from a 12-month old female Lt/Sv mouse. When injected subcu-
taneously into Swiss nu/nu mice, LTPA cells form ductular
structures (ATCC, catalog CRL-2389, Manassas, Virginia).
Although these cells are not of hepatic origin, the pancreatic
and biliary ducts are physiologically connected and have a
shared developmental origin (Probert et al., 2015). These cells
were used as they supported ERa reporter gene assays in terms
of responsiveness when compared with baseline expression
and in terms of good repeatability. The human breast cancer
cell line MCF-7 was a kind gift from Dr Katherine Rennie,
Newcastle University. The 293 (HEK293) cell line was purchased
from the European Collection of Cell Cultures (ECACC, Porton
Down, UK). E2, EE and ICI182780 were purchased from Sigma
(Poole, UK).
Soil sample collection and extract preparation. Soil samples (of
approximately 0–5 cm in depth) were collected around the perim-
eter (within 200 m) to an active landfill site (located within a peri-
urban area) which does not have a license to accept hazardous
materials. In addition, 3 control soil samples were similarly col-
lected from 3 separate sites. One sample was obtained from the
University farm in rural Northumberland at a site with controlled
fertilizer regime for the last 130 years and the remaining 2 control
samples were obtained from gardens in urban areas in the region.
Extraneous vegetable matter and stones removed, manually
homogenized and stored at 5C until downstream use. 125 g soil
was sonicated in 300mls methanol for 10 min, followed by addi-
tion of a further 100 ml of solvent and sonication for a further
10 min prior to filtration with 25 mm filters and collection of fil-
trate. Filtrates were evaporated in a rotary evaporator and then
blown down to near dryness under a stream of nitrogen prior to
addition of 30 ml of ethanol. The solvated extracted chemicals
were separated from any precipitate and stored at 20C.
Recombinant DNA cloning. The mouse (henceforth prefixed with
an m; human receptor prefixed with an h) mERa and mERb var-
iant 1 (m mERbv1) and variant 2 (mERbv2) cDNAs were ampli-
fied from mRNA isolated from mouse uterus and mouse ovary,
respectively, using the following primers, mERacloning, US,
50- CGCCGAATTCCACTTACCATGACCATG-30 DS, 50- CCTGGAAGCT
TTCAGATCGTGTTGGGG-30; mERßcloning, US, 50- CCGTGAATT
CCTGAGAGCATCATGTCCA-30 DS, 50- TCCGCCTTAAGCCTGGC
CGTCACTG-30 to give HindIII and EcoRI restriction sites for mERa
and AflII and EcoRI sites for mERb cDNA products. The PCR prod-
ucts were initially cloned into a pCR-blunt vector using the Zero
Blunt PCR Cloning Kit (Life technologies) prior to sub-cloning
into pcDNA3.1 restricted with the appropriate restriction enzymes.
Constructs were screened for correct insertion by restriction digest
analyses and sequence integrity by DNA sequencing.
Cell line culture. 603B, MCF-7 and 293 cells were cultured in low
glucose Dulbecco’s Modified Eagles Medium (Sigma, Dorset, UK),
supplemented with 10% (v/v) foetal bovine serum (Sigma) and
80 U/ml of penicillin and streptomycin. LTPA cells were cultured
in the above medium further supplemented with 0.1 mM non-
essential amino acids (Gibco, Life technologies, Paisley, UK) and
1 mM sodium pyruvate (Gibco, Life technologies). All cell lines
were maintained in a humidified atmosphere at 37 C in 5% CO2
in air.
RT-PCR. Total RNA was purified using Trizol (Invitrogen, Paisley,
UK). RT-PCR was carried out as previously outlined (Probert
et al., 2014) and using primer sequences given in Table 1.
Transfection and reporter gene assays. 603B and LTPA cells were
transiently transfected in 24-well plates with 0.25 lg total DNA
per well (pcDNA3.1 expression vector encoding the cDNAs for
either the mERa, mERbv1, mERbv2, mouse c/EBPb or an empty
construct (ie, pcDNA3.1); an oestrogen-responsive reporter gene
luciferase construct, either (ERE)3-pGL3promoter (Axon et al.,
2012) or 3XERE TATA Luc (Hall and McDonnell, 1999; obtained
via Adgene plasmid no. 11354) and a control plasmid (RL-TK)
encoding the Renilla luciferase protein under the regulation of a
constitutive thymidine kinase promoter to control for transfec-
tion efficiency between wells at a ratio of 6, 6, 1) using Effectene
reagent (Qiagen, Manchester, UK), according to the manufac-
turer’s instructions. The mERa failed to transactivate the (ERE)3-
pGL3promoter in response to E2 treatment (data not included)
and therefore the 3XERE TATA Luc previously shown to respond
to mouse ERa activation (La Sala et al., 2010) was employed.
Twenty-four hours after transfection, cells transfected with the
pcDNA3.1 constructs coding for the mERa or mERbv1 were,
where applicable, pre-treated with the ER antagonist ICI182780
for 6 h before being treated with oestrogens or potential xenoes-
trogens from 1000-fold concentrated stocks in DMSO or PBS.
Since the mERbv2 exhibited near complete constitutive activity
in vitro, cells transfected with the pcDNA3.1 construct encoding
the mERbv2 were pre-treated with the ER antagonist ICI182780
for 6 h followed by 5 wash steps with large volumes of sterile
PBS to reduce the levels of antagonist. Cells were then treated
with oestrogens or potential xenoestrogens from 1000-fold con-
centrated stocks in DMSO or PBS in the absence, and where
indicated, in the presence of ICI182780. Following treatment for
24 h, Firefly and Renilla luciferase activities were determined
using a Dual-Glo luciferase assay kit (Promega) as previously
described in Axon et al. (2012). Charcoal-stripped serum was not
used (to reduce serum oestrogens) unless explicitly indicated
since in our hands, avoiding this procedure produced high
readout-to-background data with reduced intra-experimental
replicate variability (although inter-experimental maximum
fold induction was more variable). When charcoal-stripped
serum was used, sera were prepared as previously outlined
(Axon et al., 2012), in some cases in conjunction with phenol
red-free culture medium.
Cholangiocyte isolation and culture. Male C57Bl/6 wild type mice
were terminated by cervical dislocation. The liver was removed
and 6–7 pooled, minced using a scalpel in 25 ml Hank’s balanced
salt solution plus calcium (HBSSþ, 0.14M NaCl, 5.4 mM KCl, 0.34
mM Na2HPO4 12H2O, 0.44 mM KH2PO4, 5.6 mM glucose, 6 mM
HEPES, 0.35 g/l NaHCO3 and 1 mM CaCl2) supplemented with
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1 mg/ml collagenase type 1A (Sigma) and 80 lg/ml DNAse
I (Sigma). After 30–45 min incubation at 37 C, the digest was fil-
tered through a 125 lm Nybolt mesh and the resultant cell sus-
pension made up to 100 ml with HBSSþ. Cells were pelleted by
centrifugation at 600 g for 5 min at room temperature. This
washing step was repeated twice and the final cell pellet
re-suspended in 12 ml HBSSþ. Mouse cholangiocytes were
semi-purified by density gradient centrifugation as previously
described using percoll density centrifugation (Joplin et al., 1989)
(without additional anti-HEA125 affinity purification since the
antibody did not immunoreact with its murine ortholog in our
hands and offered no improvements in purity or yield). Percoll
(GE Healthcare) was diluted 9:1 (v/v) with 10 PBS (1.37M NaCl,
27 mM KCl, 100 mM phosphate pH 7.4). This stock was diluted
1:2 (v/v) with 1 PBS (137 mM NaCl, 2.7 mM KCl, 10 mM phos-
phate pH 7.4) and 3 ml was layered onto 3 mls of stock diluted
1:0.3 (v/v) with 1 PBS in a 13 ml sterile falcon tube. In total,
3 ml of cells suspension (in HBSSþ) was then layered onto the
top of each percoll layer followed by centrifugation at 670 g for
30 min at 80% acceleration and 0% deceleration in a swing out
rotor. The lower percoll/percoll interface was enriched in chol-
angiocytes and these were collected, added to 3 volumes of
1PBS, pelleted by centrifugation at 600 g for 5 minutes and re-
suspended in culture media (1:1 [v/v] DMEM, Hams F12 medium
supplemented with 10% (v/v) FBS, 2 mM glutamine, 100 U/ml
penicillin, 100 lg/ml streptomycin, 10 ng/ml epidermal growth
factor, 0.248 IU/ml Insulin, 2 mg/ml hydrocortisone, 10 ng/ml
cholera toxin, 2nM tri-iodo-L-thyronine and 5 ng/ml hepatocyte
growth factor. Cells were seeded onto plastic culture dishes and
maintained in a humidified atmosphere at 37 C in 5% CO2 in air.
Immunocytochemistry. Cells were fixed with 4% formaldehyde
(Sigma) in PBS for 10 min followed by permeabilization with 0.2%
(w/v) Triton in 1 PBS for 15 min. Non-specific protein binding was
blocked by incubation with 5% goat serum in 1 PBS-T (PBS þ
0.02% w/v Tween 20) for 20 min at room temperature. Cells were
incubated with anti-cytokeratin 19 (CK19) (Abcam, ab 84632) plus
anti-ERa (Abcam, ab2746) or anti-ERb (Abcam, ab288) primary anti-
bodies in blocking buffer at 4 C overnight. Following three 10-min
washes in PBS-T, cells were incubated with the appropriate secon-
dary antibodies (Cell signaling, 4412S and 4414S) in blocking buffer
for 45 min in the dark. Cell nuclei were stained with DAPI prior to
mounting using Fluoroshield mountant (Sigma).
Western blotting. Total protein was isolated from cell and tissue
samples using RIPA buffer (150 mM sodium chloride, 1.0% Triton
X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate,
50 mM Tris, pH 8.0), 30 min agitation at 4 C. 4 LDS sample buffer
(Life Technologies) and 5% v/v 2-mercaptoethanol was added to
cell lysates, samples were boiled for 5 min at 95 C and the
genomic DNA sheared by sonication. Proteins were separated
using pre-cast 4–12% Bis-Tris polyacrylamide gels (NuPAGE, Life
Technologies) and then transferred to nitrocellulose membranes
using the iBlot device (Life technologies). Membranes were
probed using standard protocols with the following primary anti-
bodies, Rabbit polyclonal antibodies to ERa (Santa Cruz
Biotechnology, sc-7207, 1, 500 dilution) and ERb (Abcam, ab3576,
1:1000 dilution). Anti-GAPDH antibody was purchased from Cell
Signaling (2118S, 1:5000 dilution). Appropriate HRP-conjugated
anti-IgG antibodies were used for detection using the ECL
reagent (GE Healthcare). Protein bands were visualized using a
Syngene G, Box gel documentation system.
Animal study. Male adult C57Bl/6 wild type mice were purchased
from Charles River (Kent, UK) and housed in accordance with
UK Home Office regulations. Males were chosen over females
because the female oestrus cycle results in more variable levels
of endogenous oestrogens in test groups of animals, which
would result in more mice per test group being required to
assess any potential effects of a xenoestrogen. On a 3Rs basis, it
was considered more ethical to test any potential effects of xen-
oestrogens on as few mice as possible, and so male mice were
selected. Food and water for animals were available ad libitum
and conditions were kept at 23 6 1 C on a 12-h light/12-h dark
cycle at 47% humidity. Mice were exposed to combined and con-
centrated soil extracts which have been shown to exhibit oes-
trogenic activity in a reporter gene assay or to combined soil
extracts from the 3 control sampling sites without any
TABLE 1. Primers used for Cloning and RT-PCR
Oligo ID 50-30 sequence Annealing (C) Comments
mERaUS AAGGGCAGTCACAATGAACC 59 Will amplify mouse ERa (NM_007956) cDNA
sequence of 155 bpmERaDS GCCAGGTCATTCTCCACATT
mERbUS GGGTGAAGGAGCTACTGCTG 59 Will amplify mouse ERb transcript variants 1 and 2
(NM_207707 and NM_010157) cDNA sequence of
576 and 522 bp, respectively
mERbDS GTGTCAGCTTCCGGCTACTC
mGAPDHUS TGACATCAAGAAGGTGGTGAAG 55 Will amplify mouse (NM_008084) glyceraldehyde 3
phosphate dehydrogenase cDNA sequence of
243 bp
mGAPDHDS TCTTACTCCTTGGAGGCCATGT
mCK19US GAGATCATGGCCGAGAAGAA 55 Will amplify mouse cytokeratin 19 (NM_008471.2)
cDNA sequence of 72 bpmCK19DS GGTGTTCAGCTCCTCAATCC
mVimentinUS GTGGCTCCGGCACATCGAGC 56 Will amplify mouse vimentin (NM_011701.4) cDNA
sequence of 226 bpmVimentinDS GCGTCGGCCAGCGAGAAGTC
mCYP2E1US GTGTTCCGAGGATATGTCATC 56 Will amplify mouse CYP2E1 (NM_021282.2) cDNA
sequence of 223 bpmCYP2E1DS AAAGCAGAAACAGTTCCATGC
mERaCloningDSHindIII CCTGGAAGCTTTCAGATCGTGTTGGGG 72 Will amplify mouse ERa transcript variants 1, 2 and 3
(NM_007956.5, NM_001302531.1, NM_001302532.1)
cDNA sequence of 1829 bp (2-step PCR)
mERaCloningUSEcoRI CGCCGAATTCCACTTACCATGACCATG
mERbUScloning TCCGCCTTAAGCCTGGCCGTCACTG 65 Will amplify mouse ERb transcript variants 1 and 2
(NM_207707 and NM_010157) cDNA sequence of
1744 and 1690 bp, respectively
mERbDScloning TCCGCCTTAAGCCTGGCCGTCACTG
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detectable oestrogenic activity by single intraperitoneal injec-
tion. Other groups received either ethinyloestradiol (EE, Sigma,
Poole, UK) at 0.5 mg/kg bodyweight in 90% olive oil/10% ethanol
vehicle or vehicle alone. For preparation of the extracts, com-
bined oestrogen positive or oestrogen negative soil ethanol
extracts were dried down under a stream of nitrogen and re-
suspended in 90% olive oil/10% ethanol (v/v) at half the original
volume. All animals were dosed at 20 ml per kg bodyweight.
Mice were terminated 24 h postinjection and their blood and liv-
ers were collected. Experiments were performed under a UK
Home Office licence with Local Ethics Committee approval.
Clinical chemistry And histology. Blood was collected at termina-
tion, serum prepared and clinical chemistry (ALP, ALT) deter-
mined as described (Marek et al., 2005). Following dissection,
livers were fixed in 10% PBS buffered formalin for 24 h before
paraffin embedding and sectioning at 4 lm. Tissue sections
were stained with Haematoxylin and Eosin as previously
described in Probert et al. (2014).
RESULTS
Extracts from Soil Samples around a Landfill Site Contain Activators
of the Human ERa
MCF-7 cells were transiently transfected with the (ERE)3-
pGL3promotor using a previously validated protocol for screen-
ing hERa transcriptional activity (Axon et al., 2012) and treated
with ethanol extracts from soil samples taken from around an
urban landfill site (landfill site soil samples). The ethanol sol-
vent stock used in the soil extraction procedure was used as sol-
vent control. Identical procedures were used to obtain extracts
from 3 different sites not in close proximity to an urban landfill
site (control site soil samples).
Figure 1A demonstrates that media supplemented with
ethanol extracts effectively diluted by medium by a factor of
1000 (ie, constituting a final 0.1% v/v) resulted in significant
increases in normalized luciferase reporter gene expression in
several sampling sites around the landfill site and to levels sim-
ilar or greater than that induced by treatment with a biological
fully saturating 10nM E2 or 10 nM EE. In contrast, no significant
increase in normalized luciferase reporter gene expression was
observed when cells were treated with similarly diluted ethanol
extracts from 3 control site soil samples.
Normalized luciferase reporter gene expression was
increased by selected landfill site ethanol extracts in a dose–
response manner (Figure 1B) and was inhibited by the ER antag-
onist ICI182780 but not by RU486 (an antagonist for other
nuclear receptors) (Figure 1C). These data therefore indicate
that ethanol extracts from soil samples in close proximity to an
urban landfill site contained a chemical(s) that was capable of
producing a readily detectable activation of the hERa in a cell-
based biological reporter gene assay.
Extracts from Soil Samples around a Landfill Site Activate the
Murine ERs
The mouse was considered the preferred animal model in
which to study the potential effects of xenoestrogens (given, for
example, the availability of a variety of transgenic lines in fol-
low on studies). Since cholangiocytes on a background of dis-
ease express both ERs in rats and man (Alvaro et al., 2000,
2002a,b, 2004, 2006), cholangiocytes isolated from mouse liver
were initially examined as the cell type for examining ER activa-
tion. However, mouse cholangiocytes resisted transfection (data
not shown) and therefore cell lines were used as an alternative.
Only 2 cell lines were available, LTPA and 603B cells. Figure 2A
demonstrates however, that mER mRNA transcripts were not
readily detectable in these cell lines, with likely a very low
expression of mERa mRNA in 603B cells only. In any case, ER
proteins were undetectable in both cell lines (Figs. 2B and C).
In order to study ER function in these cells, the protein encoding
murine mER cDNAs were therefore cloned and ligated into
expression vectors to facilitate their ectopic expression.
The mERa cDNA was cloned as outlined in the methods
section and expressed in LTPA cells (603B cells were resistant
to ERa expression, data not included). Figures 3A and B dem-
onstrates low but detectable expression of mERa protein in
these cells (compared with mouse uterus or to the mERa
transfected HEK293 cell line or to high hERa-expressing MCF7
human breast cancer cells). LTPA cells expressing mERa trans-
activated the 3XERE TATA Luc reporter gene constitutively
(likely due to oestrogens present in the cell media) since the
ER antagonist ICI182780 significantly reduced constitutive
luciferase gene expression (Figure 3C). However, addition of
10nM E2 significantly further induced luciferase gene expres-
sion confirming that the mERa construct produced functional
protein and that the LTPA cells express co-factors permissive
for mERa transcriptional responsiveness. The response of the
3XERE TATA Luc reporter gene to E2 or EE was concentration-
dependent (Figure 3D) and treating LTPA cells with extracts
from soils demonstrated that the extracts which activated the
hERa in human MCF7 cells also activated the mERa in LTPA
cells, an effect that was blocked by the ER antagonist
ICI182780 (Figure 3E).
Two mERb sequences were amplified by RT-PCR from mouse
ovary RNA template (see Figure 2A) and after cloning and
sequence analysis, both were observed to be identical to
NM_207707.1 [full length; variant 1] and NM_010157.3 [variant 2]
lacking an in-frame exon in the coding region, compared with
mERbv1 resulting in a protein lacking amino acids 383–400 seen
with mERbv1. For alignment of cDNA and amino acid sequences
see Supplementary Figure S1. Figures 4A and B demonstrate
that proteins of the predicted size were generated and localized
to the nucleus in cells respectively when the proteins were
expressed in HEK293 cells with low levels detectable in 603B
cells. Figure 4C demonstrates that 603B cells expressing mERbv1
trans-activated the (ERE)3-pGL3promoter reporter gene consti-
tutively (likely due to oestrogens present in the cell media) since
co-addition of the ER antagonist ICI182780 significantly reduced
luciferase gene expression. However, addition of 10 nM E2 sig-
nificantly further induced luciferase gene expression confirm-
ing that the mERbv1 construct produced functional protein and
that the 603B cells expressed co-factors permissive for mERb
responsiveness. In contrast, mERbv2 appeared to be constitu-
tively fully activated since the ER antagonist ICI182780 signifi-
cantly reduced luciferase gene expression to levels also seen
with ICI182780 treatment with mERbv1 and addition of 10 nM E2
did not result in further induced luciferase gene expression
(Figure 4C). Figure 4D demonstrates that the response of the
(ERE)3-pGL3promoter reporter gene to E2 or EE was
concentration-dependent when the cells expressed mERbv1. An
absence or a limited response was observed with E2, and only a
weak concentration-dependent response was observed with EE
when mERbv2 was expressed (Figs. 4D and E).
Serum constituents and the culture medium pH indicator
phenol red have been shown to be activators of ERs (Berthois
et al., 1986). We therefore examined the influence of medium
constituents and phenol red on mERbv1 and ERbv2
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FIG. 1. Extracts of soil samples in close proximity to a landfill site contain a chemical(s) that activate the human ERa. A, luciferase reporter gene (ERE)3-pGL3promoter
assay in MCF7 cells. Cells were transfected as outlined in the methods section and treated with 0.5% v/v ethanol extracts, E2 or EE for 1 day prior to analysis. B, concen-
tration-dependent luciferase reporter gene assay in MCF7 cells treated essentially as outlined in A with the indicated dilution of landfill site soil extract 3 or control
extract 3. C, MCF7 were cells treated essentially as outlined in A except cells were pre-treated for 5 h with the indicated nuclear receptor antagonist or solvent vehicle
as control prior to exposure to soil sample extracts, E2 or EE for 1 day. Data are the mean and SD normalized luciferase activity from 3 entirely separate determinations
of the same conditions performed within the same experiment, typical of at least 3 separate experiments performed at different times, significantly different versus
*ethanol solvent control or #antagonist-free treated cells using the Student’s t test (2-tailed), P < .05.
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FIG. 2. Expression of murine ERs in murine pancreatohepatobiliary cell lines. A, RT-PCR analysis for the indicated mRNA transcript in mouse 603B or LTPA cell lines
and comparison to intact mouse tissues. B, Western blot for the indicated protein in ductal cell lines or the indicated murine tissue (20lg total protein/lane). C, immu-
nocytochemical analysis for ER expression in murine pancreatobiliary cell lines and in HEK293 cells transfected with an expression vector encoding the indicated
ER cDNA.
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FIG. 3. Extracts of soil samples in close proximity to a landfill site contain a chemical(s) that activate the mouse ERa in a murine ductal (LTPA) cell line. A, Western Blot
(20lg total protein/lane) for the expression of the mouse ERa protein in LTPA and HEK293 cells transfected with the expression construct encoding the mouse ERa
cDNA sequence. B, immunocytochemical analysis for ERa expression in LTPA or HEK293 cells transfected with an expression vector encoding the mERa cDNA
sequence. C, luciferase reporter gene (3XERE-TATA) assay in LTPA cells co-transfected with expression constructs encoding the indicated protein. Data are the mean
and SD normalized luciferase activity from 3 entirely separate determinations of the same conditions performed within the same experiment, typical of at least 3 sepa-
rate experiments performed at different times. *Significantly different (P < .05) versus the equivalent expression vector transfected DMSO vehicle-treated cells; #signifi-
cantly different (P < .05) versus equivalent treatments in the absence of ICI182780-treated cells using the Student’s t-test (2-tailed).
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FIG. 3. Continued
D, luciferase reporter gene (3XERE-TATA) assay in LTPA cells co-transfected with expression construct encoding the mERa and comparison to
cells transfected with an empty expression construct. Data are the mean and SD normalized luciferase activity from 3 entirely separate deter-
minations of the same conditions performed within the same experiment, typical of at least 3 separate experiments performed at different
times. *Significantly different (P < .05) versus empty vector transfected cells treated with the same concentration of E2 or EE. E, luciferase
reporter gene (3xERE-TATA) assay in LTPA cells. Cells were transfected as outlined in the methods section and treated with 0.1% v/v ethanol
extracts, E2 or EE for 24 h prior to analysis. Data are the mean and SD normalized luciferase activity from 3 entirely separate determinations of
the same conditions performed within the same experiment, typical of at least 3 separate experiments performed at different times.
*Significantly different (P < .05) versus the equivalent expression vector transfected DMSO vehicle-treated cells; #significantly different (P < .05)
versus equivalent treatments in the absence of ICI182780-treated cells using the Student’s t-test (2-tailed).
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FIG. 4. Extracts of soil samples in close proximity to a landfill site contain a chemical(s) that activate the mouse ERb variants 1 and 2 in a murine pancreatohepatobiliary ductal
(603B) cell line. A, Western Blot (20lg total protein/lane) for the expression of the mouse ERb proteins in LTPA and HEK293 cells transfected with the expression construct encod-
ing either the mouse ERb variant 1 (ERbv1) or ERb variant 2 (ERbv2) cDNA sequences—theoretical molecular weights, variant 1, 63.23kDa; variant 2, 61.21kDa).
B, Immunocytochemical analysis for ERb expression in 603B or HEK293 cells transfected with an expression vector encoding either the mERb variant 1 or mERb variant 2 cDNA
sequence.
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FIG. 4. Continued
C, luciferase reporter gene (ERE)
3
-pGL3promoter) assay in 603B cells co-transfected with expression constructs encoding the indicated protein.
Data are the mean and SD normalized luciferase activity from 3 entirely separate determinations of the same conditions performed within the
same experiment, typical of at least 3 separate experiments performed at different times. *Significantly different (P < .05) versus the equivalent
expression vector transfected DMSO vehicle-treated cells; #significantly different (P < 0.05) versus equivalent treatments in the absence of
ICI182780-treated cells using the Student’s t-test (2-tailed). D, luciferase reporter gene (ERE)
3
-pGL3promoter assay in 603B cells co-transfected
with expression construct encoding the mERbv1 or mERbv2 and comparison to cells transfected with an empty expression construct. Cells
were treated with the indicated concentration of either E2 (upper) or EE (lower). Data are the mean and SD normalized luciferase activity from 3
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transcriptional functional to determine whether ERbv2 is more
readily activated by culture medium constituents. Figure 4E
suggests that the removal of these potential endogenous cul-
ture media constituents has little overall effect on fold activa-
tion by E2 or fold inhibition by ICI182780. Notably, the
apparent inhibition of constitutive mERbv2 transcriptional
function by ICI182780 is not lost when the assay is performed
in cells cultured in charcoal-stripped and phenol red-free
medium, suggesting these factors were not responsible for its
constitutive activation. Figure 4F indicates however, that de-
activation of the mERbv2 in 603B cells with pre-treatment with
IC182780 followed by a washout and treatment with a range of
FIG. 4. Continued
entirely separate determinations of the same conditions performed within the same experiment, typical of at least 3 separate experiments per-
formed at different times. *Significantly different (P < 0.05) versus empty vector transfected cells treated with the same concentration of E2 or
EE. E, luciferase reporter gene (ERE)
3
-pGL3promoter assay in 603B cells and co-transfected with the indicated expression construct (with
RL-TK)—effect of performing the study in medium supplemented with normal serum, charcoal-stripped serum or charcoal-stripped serum
and medium lacking phenol red. Cells were grown in the indicated media for 24 h before transfection. Twenty-four hours after transfection,
cells were pre-treated with 100 nM ICI182780 or DMSO vehicle as indicated for 6 h followed by treatment with E2 or DMSO vehicle (6 ICI182780)
for 24 h. Data are the mean and SD normalized luciferase activity from 3 entirely separate determinations of the same conditions performed
within the same experiment, typical of at least 3 separate experiments performed at different times. *Significantly different (P < .05) versus
vehicle-treated cells grown in the equivalent medium using the Student’s t-test (2-tailed). #Significantly different versus equivalent treatments
in the absence of ICI182780 using the Student’s t test (2-tailed). F, luciferase reporter gene (ERE)
3
-pGL3promoter assay in 603B cells co-trans-
fected with expression construct encoding the mERbv2 and pre-treated where indicated with 100 nM ICI182780 prior to addition of the indi-
cated concentration of E2 or EE. Data are the mean and SD normalized luciferase activity from 3 entirely separate determinations of the same
conditions performed within the same experiment, typical of at least 3 separate experiments performed at different times. *Significantly differ-
ent (P < .05) versus empty vector transfected cells treated with the same concentration of E2. G, Western blot for the expression of the ERa in
MCF-7 cells (left) and mERbv2 in 603B cells transfected with the pcDNA3.1-mERbv2 expression construct (right) after treatment with 100 nM
ICI182780 or DMSO vehicle for 24 and 48 h (20 lg total protein/lane).
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E2 or EE concentrations results in a robust dose–response
increase in reporter gene expression.
Previous work in mammary cells and related cell lines has
shown that the human ERa is subject to both an antagonist effect
by ICI182780, but also to a mechanistically-distinct 26S proteaso-
mal (MG132-inhibitable) mediated degradation of the protein
(Wardell et al., 2011). These observations have given rise to the
term “selective estrogen receptor degrader (SERD)” for ICI182780.
Thus, ligand-induced degradation of ERa by ICI182780 can be
saturated through adenoviral-mediated ERa over-expression,
but its ICI182780 antagonism of ERa is retained (Wardell et al.,
2011). In contrast to the human ERa, SERD activity for ICI182780
is not observed for the human ERb and in MCF7 cells, ICI182780
actually stabilized ERb protein (Peekhaus et al., 2004). Figure 4G
demonstrates that in our hands, ICI182780 treatment resulted in
a loss of hERa protein in MCF7 cells (in agreement with Wardell
et al., 2011), but not mERbv2 in 603B cells. The lack of any effect of
ICI182780 on mERbv2 protein in 603B cells was therefore similar
to the effects observed on hERb by Peekhaus et al. (2004) and sug-
gests that re-activation of mERbv2 by ICI182780 in 603B cells was
not associated with SERD-like changes in protein stability.
Therefore, the murine mERbv2 was constitutively active and
required de-activation to be responsive to oestrogens E2 or EE in
603B cells.
Treating 603B cells with extracts from soils demonstrated
that the extracts which activated the hERa in MCF7 cells also
activated the mERbv1in 603B cells (Figure 5A). Prior deactivation
with ICI182780 also permitted the mERbv2 to be activated by
some of the extracts from soils. In some cases, such as soil sam-
ple 1, only mERbv1 was activated whereas soil sample 3 con-
tained a chemical(s) that activated both of the mERbv1 and
mERbv2 (Figure 5B). However, despite effective antagonism by
ICI182780 versus E2- or EE-activation of mERbv2, the majority of
soil extract samples were resistant to subsequent antagonism
by ICI182780 (Figure 5B).
ER Expression in Mouse Cholangiocytes
Although ERa and ERb are known to be expressed in human and
rat cholangiocytes and markedly upregulated in disease settings
(Alvaro et al., 2004, 2006), there is limited data in the literature
regarding mER expression in mouse cholangiocytes. Xia et al.
(2012) report that both mERa and mERb mRNA transcripts are
expressed in mouse cholangiocytes and that expression of both
increase with culture. Isse et al. (2010) demonstrated that the role
of ERa in murine and human cholangiocytes—at least in
females—is in the regulation of interleukin 6 expression.
Cholangiocytes were therefore isolated from mouse liver as out-
lined in the methods section, giving rise to a population of cells
that were morphologically pure at isolation and which proliferated
in culture (Figure 6A). The cells were expandable over 1–2 passages
but then either senesced or became overgrown by fibroblasts and/
or underwent epithelial-mesenchymal trans-differentiation to
fibroblasts as evidenced by high vimentin mRNA expression
(Figure 6B). In our hands, there was little evidence for expression of
mER proteins in isolated mouse cholangiocytes. However, with
culture, during which time the cells expanded in number and
retained their epithelial morphology, the cells expressed detect-
able levels of mERb as determined by immunocytochemistry
(Figure 6C) and Western blotting (Figure 6D).
Acute Exposure to Oestrogen Positive Soil Extract Results in
Cholangiopathic Injury in the Absence of any Hepatocellular Injury
To examine whether any of the soil extracts have any hepatic
effects, soil extracts were combined and concentrated and male
mice were acutely exposed to extracts via an intraperitoneal
route of exposure. Figure 7A demonstrates that the combined
soil extracts demonstrating oestrogenicity resulted in a signifi-
cant increase in serum alkaline phosphatase (ALP) activity,
a clinical marker for cholangiopathy, although there was a sig-
nificant decrease in serum alanine aminotransferase activity
(ALT), a marker for hepatocellular injury. EE treatment also
resulted in a small but significant increase in ALP and in some
mice, elevated serum ALT, although overall there was not a sig-
nificant increase over this period of exposure. However, no
marked histological changes were noted in liver sections (Figure
7B), suggesting that these changes in clinical chemical markers
occurred in the absence of any overt cell death.
DISCUSSION
The data in this article provide proof of concept that it is possi-
ble to detect xenoestrogenic activity in soil extracts and that
measurably high levels can be detected in landfill site soil sam-
ples compared with control site soil samples not in proximity to
landfill sites and not expected to be contaminated with chemi-
cals such as pesticides. The study has been performed in an his-
toric mining area therefore, to gain access to the most recently
deposited material, surface sediments were taken. To our
knowledge, this approach has not been employed before. The
xenoestrogens present in landfill site soils were shown to acti-
vate the hERa in a dose–response manner, an effect that was
antagonized by the ER antagonist ICI182780. However, the
chemical identity(ies) of the xenoestrogen(s) present in the soil
around the landfill site were not investigated. Given the wide
range of natural and man-made chemicals shown to activate ERs
(Axon et al., 2012; Kuiper et al., 1998; Laws et al., 2000) and the vari-
ety of chemicals potentially present in soils around a landfill site,
the responses observed are likely to be related to mixtures of
agonistic and antagonistic chemicals in combination with non-
interacting ER chemicals. Therefore, identification of the xenoes-
trogen(s) responsible for oestrogenic activities is a significant
task. However, by estimating the oestrogenic activity of cell
extracts, it is possible to estimate the biological agonistic activity
of the chemical mixture and to determine an “E2 equivalent”
activity. By applying this principle, the approximate EC50% for
landfill site 3 (1/5000 dilution) and E2 activation (1012 M) of the
hERa, these data suggest that the concentration of xenoestrogens
in landfill site soil 3 was approximately 5 nM E2 equivalents (or
likely within the range of 1–10 nM E2 equivalents).
In order to be in a position to test the potential toxicological
effects of xenoestrogen in man, an animal model is required to
take into account exposure routes, toxicokinetic and toxicody-
namic effects. Given the abundance of transgenic variants avail-
able, the mouse as a species was selected for its potential in
future mechanistic in vivo studies. Given the focus of this study
on the liver and the known expression and function of ERa in
hepatocytes, the hepatocyte would have been the preferred
option for screening the oestrogenicity of chemicals (and
remains a key goal in future studies). However, since hepato-
cytes do not undergo mitosis to any significant extent in vitro,
transfection efficiencies with hepatocytes are often too low. To
generate high signal to noise readouts that are appropriately
controlled, and given the need to screen a large set of samples
with appropriate replication (ie, at semi-high throughput), the
use of mouse hepatocytes in these studies was not a realistic
option. Given the apparent role of ERs in human cholangiocyte
biology, pancreatohepatobiliary ductal cell lines were selected
for screening studies. The availability of pancreatohepatobiliary
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FIG. 5. The mERbv2 is activated by landfill site soil xtracts after ICI182780 treatment and washout, but resists subsequent antagonism by ICI182780 in contrast to E2
and EE. A, luciferase reporter gene (ERE)3-pGL3promoter assay in 603B cells. Cells were transfected with mERbv1 as outlined in the methods section treated with 0.1%
v/v ethanol extracts, E2 or EE for 24 h prior to analysis. Data are the mean and SD normalized luciferase activity from 3 entirely separate determinations of the same
conditions performed within the same experiment, typical of at least 3 separate experiments performed at different times. *Significantly different (P < .05) versus the
equivalent expression vector transfected DMSO vehicle-treated cells; #significantly different (P < .05) versus equivalent treatments in the absence of ICI182780-treated
cells using the Student’s t test (2-tailed). B, luciferase reporter gene (ERE)3-pGL3promoter assay in 603B cells. Cells were transfected with mERbv2 as outlined in the
“Methods” section and, after 24 h, pre-treated with ICI182780 for 6 h to de-activate constitutively active mERbv2. Cells were then washed with sterile PBS to reduce the
level of ER antagonist to negligible levels followed by treatment with 0.1% v/v ethanol extracts, oestradiol (E2) or ethinylestradiol (EE) in the absence or presence of
ICI182780 for 24 h prior to analysis. Data are the mean and SD normalized luciferase activity from 3 entirely separate determinations of the same conditions performed
within the same experiment, typical of at least 3 separate experiments performed at different times. *Significantly different (P < .05) versus the equivalent expression
vector transfected DMSO vehicle-treated cells; #significantly different (P < .05) versus equivalent treatments in the absence of ICI182780-treated cells using the
Student’s t test (2-tailed).
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FIG. 6. Murine cholangiocytes express ERb at isolation and early culture periods. A, light photomicrograph of cholangiocytes in culture for 24 h. B, RT-PCR analysis for
the indicated mRNA transcript in mouse cholangiocytes at isolation, 603B cells or the indicated murine tissue. C, immunocytochemical analysis for ER expression in
cholangiocytes. Left panels after 1 day of culture, right panels after 4 days of culture. D, Western blot for the indicated protein in primary mouse cholangiocytes, cell
lines or mouse tissues as indicated (20 lg total protein/lane).
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ductal cell lines in general is limited and in our hands, mERa
was not functionally efficiently activated by any oestrogen in
the cholangiocyte 603B cells, only in the pancreatic ductal LTPA
cell line. The converse was the case for mERb variants.
The reason(s) for this is not clear but may be associated with a
divergence between these cell types and the presence of factors
required for mER transcriptional function. There may also be
limited comparability between human and murine cholangio-
cyte ER expression which may impact on the relevance of obser-
vations in mice for man. However, should this difference in
murine ERa and ERb expression extend to human pancreatohe-
patobiliary tissues, it would suggest that hERb transcriptional
function predominates in cholangiocytes (when expressed,
such as in disease settings). The data from these current studies
indicate however, that the landfill site soil extracts containing
xenoestrogen(s) activate the mERa with similar potency to the
hERa and therefore the mouse may be a good model for examin-
ing potential endocrine disruptor properties of these extracts
in vivo (eg, using the rodent uterotrophic bioassay).
In terms of the ERb, the mouse has 2 variant transcripts
which generate distinct mERb proteins. Both transcripts were
present in mouse ovary. The mERbv1 protein was transcription-
ally activated by landfill site soil extracts containing xenoestro-
gen(s) with similar potency to the hERa and mERa. However, the
mERbv2 protein was near constitutively transcriptionally fully
activated when expressed in 603B cells and required inactiva-
tion by pre-treatment with ICI18270 and wash removal for
dose–response activation by E2 or EE. To our knowledge, this
has not been previously described, and may be a unique feature
of the context in which the receptor is expressed (ie, in cholan-
giocytes). Furthermore, of potential significant toxicological sig-
nificance, this receptor retains its sensitivity to antagonism by
ICI182780 when activated by E2 or EE, but not by landfill site
soil-based xenoestrogens. Assuming that the xenoeostrogen(s)
interacts similarly with the ligand binding region of the
mERbv2, this observation suggests that the(ir) rate of dissocia-
tion is significantly reduced compared with E2. Alternatively,
the xenoestrogen(s) may interact and activate the receptor via a
different mechanism (such as through a different binding site),
rendering the receptor insensitive to ICI182780 antagonism.
Multiple variant hERb variant proteins generated from the
hERb gene have been described in man (Green et al., 2008).
Interrogation of the NCBI database at time of submission for the
existence of variant hERb transcripts indicates that at least 7
transcript variants have thus far been identified, leading to 5
variant proteins. Clustal alignment of the human and murine
ERb proteins (Supplementary Figure S2) indicates that all hERb
proteins lack the 18 amino acid insertion present in the mouse
ERb variant 1 protein and therefore hERb proteins are more
likely to respond to oestrogens and xenoestrogens similarly to
the mERbv2 protein.
The functional role of ERb in cholangiocytes under normal con-
ditions is likely to be negligible since its expression is low. However,
in clinical disease situations, it has been reported that ERb expres-
sion is markedly up-regulated (Alvaro et al., 2006) and that likely,
ERb antagonizes the pro-proliferative effects of hERa in man
(Alvaro et al., 2006). Thus, an ERb-selective agonist induced apopto-
sis in cholangiocarcinoma (Marzioni et al., 2012). Thus, it is tempt-
ing to propose that the role—in part—xenoestrogens could play in
the development of PBC is via an inhibition of bile duct proliferation
and/or promotion of vanishing bile duct syndrome through a sus-
tained activation of ERb in cholangiocytes after an initial choles-
tatic insult (be it ER dependent or independent, see Supplementary
Figure S3 for immunohistochemistry for ER expression in mouse
liver; see Supplementary Figure S4 for schematic diagram).
PBC is thought to be triggered in genetically pre-disposed
individuals through exposure to an unknown chemical(s) and/or
infectious agent(s). There is an association between use of hor-
mone replacement therapies and increased risk of having PBC
FIG. 7. Acute exposure to soil extracts containing xenoestrogens results in a
cholestatic injury in the absence of any overt pathology. A, Serum ALP (left) and
ALT (right). Data are the mean and SD activities for the indicated group 24 h after
exposure as outlined in the “Methods” section, *Significantly different (P < 0.05)
versus vehicle control treated mice. B, Haematoxylin and eosin stained liver sec-
tions from the indicated group, typical views shown with right panels, magni-
fied view of the periportal regions.
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(Gershwin et al., 2005). However, it would seem unlikely that an
endocrine disruptor such as an ERb agonist alone could be the
trigger for such a disease, on the basis of exposure alone. Taking
into consideration the mass of soil collected, the extraction pro-
cedure and the final volume of the ethanol, the concentration of
E2 equivalents in landfill site soil sample 3 is calculated to be
1200 pmol/kg soil (or in the range 240–2400 pmol E2 equivalents/
kg soil). If the oestrogenic activity in landfill site soil 3 was associ-
ated solely with E2, this is equivalent to 326 ng E2/kg soil (or in
the range 65.2–652 ng E2 equivalents/kg soil). Typical levels of E2
in a sexually mature adult female are in the range of 200–1000 pM
in serum (Sherman and Korenman, 1975; Rinaldi et al., 2006).
Assuming a serum volume of 4 l and that only serum levels of E2
are relevant, this suggests total body E2 levels of 800–4000 pmol/
person. Assuming complete oral absorption and similar distribu-
tion, metabolism and excretion to E2, to achieve biologically
equivalent levels of oestrogenic activity from landfill site soil 3
xenoestrogen would require exposure to 1.5 kg soil/person (or in
the range 3.3–0.33 kg soil/person) to lead to low level E2 activity
and 3.3 kg soil/person (or in the range [16.7–1.67 kg soil/person] to
achieve high E2 activity. Given these considerations, it is unlikely
that soil-based xenoestrogen exposure alone could trigger a PBC-
like response, but rather there may be the possibility that it is a
component of a trigger and/or sustaining process. Such a trigger
process might also include a cholestatic injury, such as exposure
to chemicals that mimic lipoic acid, resulting in their incorpora-
tion into mitochondrial proteins and which accounts for anti-
mitochondrial antibodies associated with the disease.
SUPPLEMENTARY DATA
Supplementary data are available at Toxicological Sciences
online.
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